Free Trial

UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by AEGON ASSET MANAGEMENT UK Plc

UnitedHealth Group logo with Medical background

AEGON ASSET MANAGEMENT UK Plc trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 55.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 55,173 shares of the healthcare conglomerate's stock after selling 69,210 shares during the quarter. AEGON ASSET MANAGEMENT UK Plc's holdings in UnitedHealth Group were worth $28,883,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in UNH. Richwood Investment Advisors LLC increased its stake in UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock valued at $2,654,000 after purchasing an additional 20 shares in the last quarter. Global Wealth Strategies & Associates increased its position in shares of UnitedHealth Group by 28.6% in the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after acquiring an additional 20 shares during the period. Prentice Wealth Management LLC lifted its position in UnitedHealth Group by 0.8% during the 4th quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate's stock worth $1,278,000 after acquiring an additional 21 shares during the period. 44 Wealth Management LLC increased its holdings in shares of UnitedHealth Group by 1.6% in the fourth quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock valued at $662,000 after purchasing an additional 21 shares during the period. Finally, Kolinsky Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock worth $1,080,000 after purchasing an additional 21 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several analysts have commented on UNH shares. TD Securities restated a "hold" rating and set a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Argus lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Wells Fargo & Company decreased their price target on UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Mizuho lowered their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average price target of $428.43.

Get Our Latest Report on UNH

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,533 shares of the firm's stock in a transaction dated Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director now owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Kristen Gil purchased 3,700 shares of the firm's stock in a transaction on Thursday, May 15th. The shares were purchased at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the purchase, the director now directly owns 3,818 shares of the company's stock, valued at $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded down $4.77 on Thursday, hitting $295.61. 12,188,267 shares of the company were exchanged, compared to its average volume of 6,931,682. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The stock has a market capitalization of $268.16 billion, a price-to-earnings ratio of 19.07, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a 50-day moving average price of $418.00 and a 200 day moving average price of $488.12.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the prior year, the firm earned $6.91 EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines